Literature DB >> 22079308

Predictors of warm ischemia time and perioperative complications in a multicenter, international series of robot-assisted partial nephrectomy.

Vincenzo Ficarra1, Sam Bhayani, James Porter, Nicolò Buffi, Robin Lee, Andrea Cestari, Alexander Mottrie.   

Abstract

BACKGROUND: Warm ischemia time (WIT) and complication rates are two important parameters for evaluating the perioperative results of robot-assisted partial nephrectomy (RAPN). Few data are available about the clinical predictors of WIT and overall complications.
OBJECTIVE: To identify clinical predictors of WIT and perioperative complications. DESIGN, SETTING, AND PARTICIPANTS: This is a retrospective study including 347 patients who underwent RAPN for suspicious renal cell carcinoma (RCC) at four referral centers from September 2008 to September 2010. INTERVENTION: All patients underwent RAPN using the da Vinci S Surgical System with hilar clamping. MEASUREMENTS: WIT >20 min and overall complication rates were the main outcomes. Postoperative complications were classified according to the Clavien/Dindo system. Moreover, the following perioperative variables were considered: clinical tumor size, anatomical tumor characteristics according to Preoperative Aspects and Dimensions Used for an Anatomical (PADUA) classification score, surgeon experience, console time, blood loss, and upper collecting system (UCS) repair. RESULTS AND LIMITATIONS: WIT >20 min was reported in 125 (36%) cases. Intraoperative and postoperative complications were observed in 10 (2.9%) and 41 (11.8%) cases, respectively. Surgeon experience (odds ratio [OR]: 6.381; 95% confidence interval [CI], 3.687-11.042; p<0.001), clinical tumor size (OR: 1.022; 95% CI, 1.002-1.044; p=0.03), the other anatomic characteristics determined by the PADUA classification score (OR: 1.294; 95% CI, 1.080-1.549; p=0.005), and the UCS repair (OR: 2.987; 95% CI, 1.728-5.165; p<0.001) turned out to be independent predictors of WIT >20 min. Similarly, surgeon experience (OR: 3.937; 95% CI, 2.011-7.705; p<0.001), clinical tumor size (OR: 1.033; 95% CI, 1.009-1.058; p=0.007), and the other anatomical characteristics determined by the PADUA classification score (OR: 1.427; 95% CI, 1.149-1.773; p<0.001) turned out to be independent predictors of overall complication rates. The retrospective design is the main limitation of this multicenter, international study. Therefore, some patient characteristics and comorbidities were not recorded.
CONCLUSIONS: Anatomic tumor characteristics as determined by the PADUA classification score were independent predictors of WIT and overall complications, once adjusted for the effects of surgeon experience and clinical tumor size.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079308     DOI: 10.1016/j.eururo.2011.10.046

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  35 in total

Review 1.  Laparascopic nephrectomy: different techniques and approaches.

Authors:  Tania González León
Journal:  Curr Urol Rep       Date:  2015-02       Impact factor: 3.092

2.  A multi-institutional report of peri-operative and functional outcomes after robot-assisted partial nephrectomy in patients with a solitary kidney.

Authors:  Zeynep Gul; Kyle A Blum; David J Paulucci; Ronney Abaza; Daniel D Eun; Akshay Bhandari; Ashok K Hemal; James Porter; Ketan K Badani
Journal:  J Robot Surg       Date:  2018-10-12

Review 3.  Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies.

Authors:  Aaron A Laviana; Jim C Hu
Journal:  World J Urol       Date:  2014-04-04       Impact factor: 4.226

Review 4.  Open partial nephrectomy: ancient art or currently available technique?

Authors:  Mauro Seveso; Fabio Grizzi; Giorgio Bozzini; Alberto Mandressi; Giorgio Guazzoni; Gianluigi Taverna
Journal:  Int Urol Nephrol       Date:  2015-10-05       Impact factor: 2.370

5.  Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy.

Authors:  Jeffrey J Tomaszewski; Marc C Smaldone; Reza Mehrazin; Neil Kocher; Timothy Ito; Philip Abbosh; Jacob Baber; Alexander Kutikov; Rosalia Viterbo; David Y T Chen; Daniel J Canter; Robert G Uzzo
Journal:  Urology       Date:  2014-06-10       Impact factor: 2.649

6.  Robot-assisted laparoscopic partial nephrectomy: Early single Canadian institution experience.

Authors:  Guillaume Ploussard; Richard Haddad; Evan Kovac; Patrick Richard; Maurice Anidjar; Franck Bladou
Journal:  Can Urol Assoc J       Date:  2013 Sep-Oct       Impact factor: 1.862

7.  Comparison of renal functional outcomes in exactly matched pairs between robot-assisted partial nephrectomy using warm ischemia and open partial nephrectomy using cold ischemia using diethylene triamine penta-acetic acid renal scintigraphy.

Authors:  Sangjun Yoo; Chanwoo Lee; Chunwoo Lee; Dalsan You; In Gab Jeong; Choung-Soo Kim
Journal:  Int Urol Nephrol       Date:  2016-02-20       Impact factor: 2.370

Review 8.  A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Authors:  Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill
Journal:  Eur Urol       Date:  2015-04-22       Impact factor: 20.096

Review 9.  Perioperative complications of robot-assisted partial nephrectomy.

Authors:  Eric H Kim; Jeffrey A Larson; Michael Figenshau; R Sherburne Figenshau
Journal:  Curr Urol Rep       Date:  2014-01       Impact factor: 3.092

10.  Tumor complexity and the impact on MIC and trifecta in robot-assisted partial nephrectomy: a multi-center study of over 500 cases.

Authors:  Burkhard Ubrig; Alexander Roosen; Christian Wagner; Guenter Trabs; Frank Schiefelbein; Jorn H Witt; Georg Schoen; Nina Natascha Harke
Journal:  World J Urol       Date:  2018-01-29       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.